GoodRx Holdings logo
GoodRx Holdings GDRX
$ 4.53 0.78%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

GoodRx Holdings Balance Sheet 2011-2024 | GDRX

Annual Balance Sheet GoodRx Holdings

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-18.4 M -101 M -279 M -302 M 645 M 688 M - - - - - - -

Long Term Debt

648 M 652 M 656 M 660 M 664 M 717 M - - - - - - -

Long Term Debt Current

6.18 M 4.07 M 5.85 M 4.54 M - - - - - - - - -

Total Non Current Liabilities

- - - 699 M 1.44 B 1.46 B - - - - - - -

Total Current Liabilities

123 M 76.3 M 81.1 M 59.6 M - - - - - - - - -

Total Liabilities

827 M 790 M 776 M 759 M 1.47 B 1.48 B - - - - - - -

Deferred Revenue

7.1 M 7.88 M 6.87 M 6.85 M 3.45 M 258 K - - - - - - -

Retained Earnings

-1.46 B -1.45 B -1.42 B -1.39 B -1.1 B -1.16 B - - - - - - -

Total Assets

1.59 B 1.6 B 1.61 B 1.47 B 387 M 315 M - - - - - - -

Cash and Cash Equivalents

672 M 757 M 941 M 969 M 26 M - - - - - - - -

Book Value

762 M 815 M 832 M 711 M -1.09 B -1.16 B - - - - - - -

Total Shareholders Equity

762 M 815 M 832 M 711 M -1.09 B -1.16 B - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet GoodRx Holdings

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

488 M 646 M 649 M 650 M 651 M 652 M - 654 M 655 M 656 M 657 M 658 M 659 M 660 M 660 M 660 M 660 M 664 M 664 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

658 M 806 M 827 M 797 M 784 M 790 M - 774 M 752 M 776 M 768 M 763 M 762 M 759 M 759 M 759 M 759 M 737 M 737 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

6.33 M 5.99 M 8.34 M 9.66 M 10.8 M 7.88 M - 11.5 M 10.3 M 6.87 M 8.21 M 8.9 M 8.8 M 6.85 M 6.85 M 6.85 M 6.85 M 3.45 M 3.45 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-1.45 B -1.45 B -1.43 B -1.39 B -1.45 B -1.45 B - -1.4 B -1.4 B -1.42 B -1.38 B -1.36 B -1.39 B -1.39 B -1.39 B -1.39 B -1.39 B -1.1 B -1.1 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

1.35 B 1.48 B 1.71 B 1.69 B 1.61 B 1.6 B - 1.59 B 1.54 B 1.61 B 1.61 B 1.59 B 1.51 B 1.47 B 1.47 B 1.47 B 1.47 B 387 M 387 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

424 M 525 M 795 M 762 M 761 M 757 M - 731 M 845 M 941 M 912 M 895 M 990 M 969 M 969 M 969 M 969 M 26 M 26 M - - 34.6 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

696 M 669 M 881 M 895 M 827 M 815 M - 818 M 787 M 832 M 846 M 824 M 749 M 711 M 711 M 711 M 711 M -351 M -351 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

696 M 669 M 881 M 895 M 827 M 815 M 788 M 818 M 787 M 832 M 846 M 824 M 749 M 711 M 711 M 711 M 711 M -1.09 B -1.09 B -1.13 B -1.15 B -1.16 B - - - -31.8 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency